| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |